Researchers have used a new CRISPR technology that enables them to control these microglia cells. This, according to the team, can lead to a new approach to the treatment of Alzheimer's disease. The team geared up to detect the genes that were responsible for specific states of the microglial activity. With this, they could switch the genes on and off and put the disl...
Continue reading...
Continue reading...